Potential of Quinine Sulfate for COVID-19 Treatment and Its Safety Profile: Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential of Quinine Sulfate for COVID-19 Treatment and Its Safety Profile: Review

Published:2021-12 Issue: Volume:Volume 13 Page:225-234
ISSN:1179-1438
Container-title:Clinical Pharmacology: Advances and Applications
language:en
Short-container-title:CPAA

Author:

Latarissa Irma Rahayu,Barliana Melisa Intan^ORCID,Meiliana Anna,Lestari Keri^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical)

Reference62 articles.

1. Cereda D, Tirani M, Rovida F, et al. The early phase of the COVID-19 outbreak in Lombardy, Italy; 2020. Available from: http://arxiv.org/abs/2003.09320. Accessed November 23, 2021.

2. Spread of SARS-CoV-2 in the Icelandic Population

3. Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;6736(20):31180–6. doi:10.1016/S0140-6736(20)31180-6

4. Evaluating Cinchona bark and quinine for treating and preventing malaria

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review;Frontiers in Pharmacology;2024-05-30

2. Specific Antibiotics Increase the Risk of Flare-Ups in Patients with Inflammatory Bowel Disease: Results from a Danish Nationwide Population-Based Nested Case-Control Study;Journal of Crohn's and Colitis;2024-02-17

3. Quinine’s Remains: Empire’s Medicine and the Life Thereafter;2024

4. Efficacy of Quinine Sulfate in Patients with Mild-To-Moderate COVID-19: A Randomized Controlled Trial;The Indonesian Biomedical Journal;2023-12-11

5. Current progress toward synthetic routes and medicinal significance of quinoline;Medicinal Chemistry Research;2023-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3